UBS Group’s Monopar Therapeutics MNPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $783K | Buy |
|
|||||
|
2025
Q1 | $296K | Buy |
|
|||||
|
2024
Q4 | $141K | Buy |
|
|||||
|
2024
Q3 | $3.45K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.75K | Sell |
|
|||||
|
2023
Q4 | $4.05K | Buy |
|
|||||
|
2023
Q3 | $45 | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $8.88K | Buy |
|
|||||
|
2022
Q4 | $7.47K | Sell |
|
|||||
|
2022
Q3 | $8K | Sell |
|
|||||
|
2022
Q2 | $45K | Buy |
|
|||||
|
2022
Q1 | $8K | Buy |
|
|||||
|
2021
Q4 | $10K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $4K | Sell |
|
|||||
|
2020
Q4 | $6K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $0 | Sell |
|
|||||
|
2019
Q4 | $21K | Buy |
|